Variant-specific treatment gaps: Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases

J Formos Med Assoc. 2024 Dec 10:S0929-6646(24)00572-2. doi: 10.1016/j.jfma.2024.12.013. Online ahead of print.

Authors

Chia Siang Kow¹, Dinesh Sangarran Ramachandram², Syed Shahzad Hasan¹, Kaeshaelya Thiruchelvam³

Affiliations

¹ School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
² School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
³ School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: [email protected].

PMID: 39665935
DOI: 10.1016/j.jfma.2024.12.013

No abstract available

Keywords: Anticoagulant; Coronavirus; Heparin; IL-6; Interleukin.

Publication types

Letter